Le Forum Catholique

We have already seen other drugs, repurposed for COVID-19, including hydroxychloroquine(6) and lopinavir–ritonavir,(7) report disappointing findings so far in randomised trials after early promise.

6: Tang W et al.Hydroxychloroquine in patients with COVID-19: an open-label, randomised, controlled trial. medRxiv. 2020; (published online April 14.) (preprint). https://www.medrxiv.org/content/10.1101/2020.04.10.20060558v1.full.pdf Google Scholar and lopinavir–ritonavir,7
report disappointing findings so far in randomised trials after early promise.